Phase I study of chidamide (CS055/HBI-8000), a new histone deacetylase inhibitor, in patients with advanced solid tumors and lymphomas

被引：0
|
作者：
Mei Dong
Zhi-Qiang Ning
Pu-Yuan Xing
Jia-Lian Xu
Hai-Xiang Cao
Gui-Fang Dou
Zhi-Yun Meng
Yuan-Kai Shi
Xian-Ping Lu
Feng-Yi Feng
机构：
[1] Chinese Academy of Medical Sciences,Department of Medical Oncology, Cancer Institute and Hospital
[2] Chipscreen Biosciences Ltd.,Laboratory of Drug Metabolism and Pharmacokinetics
[3] Tigermed Consulting Ltd.,undefined
[4] Institute of Transfusion Medicine,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Chidamide; HDAC inhibitor; Phase I; Solid tumor; Lymphoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1413 / 1422
页数：9
相关论文
共 50 条
  • [41] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [42] A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
    Hurwitz, Herbert I.
    Cohen, Roger B.
    McGovren, J. Patrick
    Hirawat, Samit
    Petros, William P.
    Natsumeda, Yutaka
    Yoshinari, Tomoko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (01) : 139 - 147
  • [43] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Elisabeth I. Heath
    George R. Blumenschein
    Roger B. Cohen
    Patricia M. LoRusso
    Noelle K. LoConte
    Sindy T. Kim
    Ana Ruiz-Garcia
    Richard C. Chao
    George Wilding
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 703 - 712
  • [44] A phase I study of the safety and pharmacokinetics of edotecarin (J-107088), a novel topoisomerase I inhibitor, in patients with advanced solid tumors
    Herbert I. Hurwitz
    Roger B. Cohen
    J. Patrick McGovren
    Samit Hirawat
    William P. Petros
    Yutaka Natsumeda
    Tomoko Yoshinari
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 139 - 147
  • [45] Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors
    Stathis, A.
    Hess, D.
    von Moos, R.
    Homicsko, K.
    Griguolo, G.
    Joerger, M.
    Mark, M.
    Ackermann, C. J.
    Allegrini, S.
    Catapano, C. V.
    Xyrafas, A.
    Enoiu, M.
    Berardi, S.
    Gargiulo, P.
    Sessa, C.
    INVESTIGATIONAL NEW DRUGS, 2017, 35 (06) : 766 - 772
  • [46] Sunitinib in combination with paclitaxel plus carboplatin in patients with advanced solid tumors: phase I study results
    Heath, Elisabeth I.
    Blumenschein, George R., Jr.
    Cohen, Roger B.
    LoRusso, Patricia M.
    LoConte, Noelle K.
    Kim, Sindy T.
    Ruiz-Garcia, Ana
    Chao, Richard C.
    Wilding, George
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (03) : 703 - 712
  • [47] A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors
    Wataru Okamoto
    Takayuki Yoshino
    Toshiaki Takahashi
    Isamu Okamoto
    Shinya Ueda
    Asuka Tsuya
    Narikazu Boku
    Kazuto Nishio
    Masahiro Fukuoka
    Nobuyuki Yamamoto
    Kazuhiko Nakagawa
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 1063 - 1071
  • [48] A phase I, pharmacokinetic and pharmacodynamic study of nimotuzumab in Japanese patients with advanced solid tumors
    Okamoto, Wataru
    Yoshino, Takayuki
    Takahashi, Toshiaki
    Okamoto, Isamu
    Ueda, Shinya
    Tsuya, Asuka
    Boku, Narikazu
    Nishio, Kazuto
    Fukuoka, Masahiro
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (05) : 1063 - 1071
  • [49] A phase I study of the farnesyltransferase inhibitor Tipifarnib in combination with the epidermal growth factor tyrosine kinase inhibitor Erlotinib in patients with advanced solid tumors
    Jazieh, Khalid
    Molina, Julian
    Allred, Jacob
    Yin, Jun
    Reid, Joel
    Goetz, Matthew
    Lim, Vun-Sin
    Kaufmann, Scott H.
    Adjei, Alex
    INVESTIGATIONAL NEW DRUGS, 2019, 37 (02) : 307 - 314
  • [50] A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors
    James Spicer
    Sheeba Irshad
    Joo Ern Ang
    Deborah Enting
    Rebecca Kristeleit
    Martina Uttenreuther-Fischer
    Karine Pemberton
    Katy Pelling
    David Schnell
    Johann de Bono
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 17 - 27
12345